Clinical trial
Open-Label Extension Study of Setmelanotide
NCT06596135
Study timeline
Study start (actual)2024-10-21Date precision: day
Registry last updated2026-07-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
SetmelanotideDRUG · verified · RxNorm: setmelanotide
Sponsors & collaborators
Rhythm Pharmaceuticals, Inc.lead sponsor
Mapped research locations
NashvilleTennessee, United States1SeattleWashington, United States1San DiegoCalifornia, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1GainesvilleFlorida, United States1ScottsdaleArizona, United States1RaleighNorth Carolina, United States1ChattanoogaTennessee, United States1Saint PaulMinnesota, United States1DanvillePennsylvania, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06596135 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.